Zymeworks Inc. - Common Stock — Cash Flow (NASDAQ:ZYME) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 144.11 M-118.3 M-110.04 M-33.01 M -75.32 M Cash from investing activities -53.85 M-207.25 M38.76 M26.66 M 84.44 M Cash from financing activities 108.58 M81.85 M-20.45 M-18.56 M 158.91 M Free cash flow 144.11 M-118.3 M-110.04 M-33.01 M -75.32 M

News

Here’s Why Zymeworks Inc. Paid $929M For Theravance Biopharma (NASDAQ:ZYME)

Zymeworks Inc. (ZYME) M&A Call - Slideshow (NASDAQ:ZYME) 2026-06-30

Theravance Stock Down 3% After Zymeworks Announces Buyout

Zymeworks Inc. (ZYME) M&A Call Transcript

Zymeworks Inc. (ZYME) Q1 2026 Earnings Call Transcript

Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates

uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates

Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Beat Estimates

Zymeworks at The Citizens Life Sciences Conference: Strategic Growth and Innovation

Zymeworks at Leerink Conference: Strategic Evolution and Clinical Progress

Stifel raises Zymeworks stock price target on royalty deal value

Citizens reiterates Zymeworks stock rating on strong cash position